Fresenius | FRE - أصول متداولة





أصول متداولة تغيير تاريخ
Akzo Nobel EUR 8.12B 594M 2026-06
Alcon AG USD 6.62B 171M 2026-03
AstraZeneca USD 27.97B 1.65B 2026-06
BASF EUR 38.79B 1.18B 2026-06
Bayer EUR 35.3B 2.39B 2026-03
Beiersdorf EUR 6.66B 8M 2025-12
DaVita Healthcare Partners USD 4.06B 4.68M 2026-03
Demant DKK 10.08B 128M 2025-12
E.ON EUR 28.03B 5.75B 2026-03
Essilor EUR 11.24B 770M 2026-06
Fresenius EUR 11.03B 1.03B 2025-12
Fresenius Medical Care EUR 8.11B 209.55M 2026-03
Getinge SEK 15.77B 2.39B 2026-06
Givaudan CHF 4.07B 258M 2025-12
GlaxoSmithKline GBP 17.56B 202M 2026-06
GN Store Nord DKK 4.85B 3.79B 2026-03
GRIFOLS EUR 5.25B 180M 2026-03
Hikma Pharmaceutical USD 2.64B 86M 2025-12
Lonza CHF 8B 3.41B 2025-12
Merck EUR 14.16B 932M 2026-03
Novartis USD 27.35B 744M 2026-06
Philips EUR 9.33B 454M 2026-06
Roche Holding CHF 35.44B 3.29B 2026-06
RWE EUR 45.61B 11.27B 2026-03
Sanofi EUR 31.52B 1.36B 2026-06
Smith & Nephew USD 4.63B 169M 2025-12